Evolution of Epstein–Barr Virus Infection Seroprevalence in a French University Hospital over 11 Years, Including the COVID-19 Pandemic, 2013–2023

Evolution of Epstein–Barr Virus Infection Seroprevalence in a French University Hospital over 11 Years, Including the COVID-19 Pandemic, 2013–2023

<i>Epstein–Barr virus</i> (EBV) is one of the most prevalent human viruses worldwide. The COVID-19 pandemic, with its social distancing measures, has disrupted the circulation of many viruses. Delayed EBV primary infection is known to increase the risk of secondary conditions, including...

Full description

Saved in:
Bibliographic Details
Main Authors: Aurélien Aubry, Catherine Francois, Baptiste Demey, Marie Louchet-Ducoroy, Christine Pannier, Christine Segard, Etienne Brochot, Sandrine Castelain
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Microorganisms
Subjects:
EBV
seroprevalence
COVID
primary infection
France
Online Access:https://www.mdpi.com/2076-2607/13/4/733
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-2607/13/4/733

Similar Items